Prolactin Relationship with Fertility and In Vitro Fertilization Outcomes—A Review of the Literature
Open Access
- 13 January 2023
- journal article
- review article
- Published by MDPI AG in Pharmaceuticals
- Vol. 16 (1) , 122
Abstract
Hyperprolactinemia is a known cause of amenorrhea and infertility. However, there is an increasing body of evidence suggesting that prolactin is involved in multiple physiological aspects of normal reproduction. Thus, the present paper aims to review the current literature regarding the relationship between serum prolactin level and in vitro fertilization (IVF)/intracytoplasmic sperm injection outcome and the role of dopamine agonists treatment in IVF success. Moreover, the mechanisms by which prolactin may exert its role in fertility and infertility were summarized. Although not all studies agree, the available evidence suggests that higher prolactin levels in follicular fluid are associated with increased oocytes competence, but also with positive effects on corpus luteum formation and survival, endometrial receptivity, blastocyst implantation potential and survival of low-motile sperm. Transient hyperprolactinemia found in IVF cycles was reported in most of the studies not to be related to IVF outcome, although a few reports suggested that it may be associated with higher implantation and pregnancy rates, and better-cumulated pregnancy outcomes. Administration of dopamine agonists for hyperprolactinemia preceding IVF treatment does not seem to negatively impact the IVF results, while treatment of transient hyperprolactinemia during IVF might be beneficial in terms of fertilization rates and conception rates. Due to limited available evidence, future studies are necessary to clarify the optimal level of circulating prolactin in patients performing IVF and the role of dopamine agonist treatment.Keywords
This publication has 87 references indexed in Scilit:
- Defective Soil for a Fertile Seed? Altered Endometrial Development Is Detrimental to Pregnancy SuccessPLOS ONE, 2012
- Macroprolactinemia: Diagnostic, Clinical, and Pathogenic SignificanceJournal of Immunology Research, 2012
- Parity, pregnancy and neonatal outcomes in women treated for hyperprolactinaemia compared with a control groupClinical Endocrinology, 2007
- Gene expression profiling of mid to late secretory phase endometrial biopsies from women with menstrual complaintAmerican Journal of Obstetrics and Gynecology, 2006
- The relationship between decidualization and prolactin mRNA and production at different stages of human pregnancyJournal of Molecular Endocrinology, 1995
- Leuprolide acetate elevates prolactin during ovarian stimulation with gonadotropinsJournal of Assisted Reproduction and Genetics, 1992
- Transient hyperprolactinemia has no effect on endocrine response and outcome in in vitro fertilization (IVF)Journal of Assisted Reproduction and Genetics, 1990
- The influence of transient hyperprolactinemia on hormonal parameters, oocyte recovery, and fertilization rates in in vitro fertilizationJournal of Assisted Reproduction and Genetics, 1989
- Human follicular fluid: Prolactin is biologically active and ovum fertilization correlates with estradiol concentrationJournal of Assisted Reproduction and Genetics, 1988
- Endocrine Parameters of Human Follicular Fluid and Fertilization Capacity of OocytesHormone and Metabolic Research, 1988